Navigation Links
Blood Thinning Medication Could Prevent Strokes

Anticoagulation therapy is used to treat deep vein thrombosis, which is a blood clot in veins of the legs, pelvis or arms. Researchers say several new studies show the medication ximelagatran (Exanta), could simplify anticoagulation therapy.//

In the first study, researchers studied DVT( Deep vein thrombosis) patients and compared the effectiveness and safety of ximelagatran compared to standard treatment with the anticoagulants enoxaparin (Lovenox) and warfarin (Coumadin). Current therapy for patients with acute venous thromboembolism consists of about a week of the anticoagulant heparin (Calciparine or Liquaemin) overlapped with and followed by long-term, oral anticoagulation therapy such as warfarin. Warfarin is given orally but is associated with unpredictable responses, and continued monitoring and adjustments are therefore necessary. Researchers found ximelagatran was as effective as enoxaparin/warfarin without the need for coagulation monitoring or dose adjustment.

In another study, researchers studied the effectiveness of ximelagatran compared to warfarin for prevention of strokes in patients with atrial fibrillation.It was found that the primary event rate for strokes associated with ximelagatran was 1.6 percent per year and with warfarin was 1.2 percent per year and there was no major difference between treatment groups in rates of major bleeding, but total bleeding was lower with ximelagatran.

Page: 1

Related medicine news :

1. Recommendations for Treatment of Blood Pressue
2. Blood Cells Capable of Regenerating Liver
3. Blood clots likely in long travel
4. Hemochromatosis Patients Blood is Safe
5. Blood transfusions beneficial after heart attacks
6. Blood Pressure Drug may slow wasting in burn victims
7. Levels Of Blood Proteins May Help Heart Disease Care
8. Blood test may identify ovarian cancer
9. A Blood test for suicide risk?
10. Blood Pressure Drugs maintain muscle strength
11. Blood test diagnoses heart failure in short time
Post Your Comments:

(Date:10/13/2017)... ... , ... “America On The Brink”: the Christian history of the United States ... creation of published author, William Nowers. Captain Nowers and his wife, Millie, have ... thirty years in the Navy. Following his career as a naval aviator and ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 ... characterized by frequent cessation in breathing. Oral appliances can offer significant relief to ...
(Date:10/12/2017)... ... 2017 , ... The company has developed a suite of ... authorities worldwide. From Children’s to Adults 50+, every formula has been developed by ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, Preservative ...
(Date:10/12/2017)... ... , ... The American College of Medical Informatics (ACMI) will present the 2017 ... Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is ... pioneer in the field of medical informatics, this prestigious award is presented to an ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... system that we intend to develop to enable prevention of a major side ... severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Lilly and Company (NYSE: LLY ) will ... 2017 on Tuesday, October 24, 2017. Lilly will also ... investment community and media to further detail the company,s ... at 9 a.m. Eastern time. Investors, media and the ... conference call through a link that will be posted ...
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, Inc. ... earnings conference call and webcast on Friday, November 3, ... (EDT) and ending at approximately 8:30 a.m. (CDT) / ... the company,s 2017 financial performance and guidance for 2018, ... initiatives to enhance operational performance, and long-range financial outlook ...
(Date:9/25/2017)... AMSTERDAM , Sept. 25, 2017   ... Trial Master File solutions, today—from the IQPC Trial ... Amsterdam , NL)—announced that EastHORN Clinical Services ... its clinical programs and TMF management. EastHORN, a ... Montrium,s eTMF platform to increase transparency to enable ...
Breaking Medicine Technology: